FRTX — Fresh Tracks Therapeutics Share News
0.000.00%
Last trade - 00:00- $5.59m
- -$5.28m
- $8.01m
Brief: Brickell Biotech Plans To Hold Special Meeting Of Stockholders On June 30, To Consider Another Reverse Stock Split Proposal
Brickell Biotech Inc reports results for the quarter ended in March - Earnings Summary
Brief: Brickell Biotech Reports Q1 2022 Results And Provides Corporate Update
Brickell Biotech Inc expected to post a loss of 6 cents a share - Earnings Preview
ASX-listed Botanix Pharmaceuticals soars on buying rights to dermatology drug
Brief: Brickell Biotech Announces Sale Of Sofpironium Bromide To Botanix Pharmaceuticals
Brickell Biotech Inc reports results for the quarter ended in December - Earnings Summary
Brief: Brickell Biotech Reports Fourth Quarter, Full Year 2021 Financial Results
Brickell Biotech Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Brickell Biotech Selected For A Late-Breaking Oral Presentation Of Us Phase 3 Pivotal Cardigan I And Cardigan Ii Study Results For Sofpironium Bromide Gel, 15% At The 2022 Aad Annual Meeting
Brickell Biotech Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Brickell Biotech Acquires Exclusive Global Rights To Portfolio Of Novel Sting Inhibitors
U.S. STOCKS ON THE MOVE-Gaming stocks, Kohl's, U.S. airlines
Brickell Biotech rises after H.C. Wainwright initiates coverage with 'buy'
Brief: Brickell Says Nasdaq Granted Additional 180 Days To Regain Compliance With Requirement
Brickell Biotech Inc reports results for the quarter ended in September - Earnings Summary
Brief: Brickell Biotech Reports Third Quarter 2021 Financial Results And Provides Corporate Update
U.S. STOCKS ON THE MOVE-Ford, Hut 8 Mining, Rafael Holdings, Spotify
Brief: Brickell Biotech Inc Prices Public Offering Of Common Stock